CNS Pharmaceuticals Inc. (CNSP)
Market Closed
30 Sep, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
5. 30
+0.39
+8.009%
$
7.53M Market Cap
- P/E Ratio
- Div Yield
8,020 Volume
0 Eps
$ 4.91
Previous Close Investors:
Want to track CNSP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CNS Pharmaceuticals Inc. (CNSP) Statistics
Valuation metrics
Market Cap 7.53M
Enterprise value -12.78M
Trailing P/E (ttm) -0.21
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 1.85
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.77
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.3K
Average volume (90 days) 9.6K
Price summary
52-Week low 1.9
52-Week high 10.59
Beta -
50-Day moving average 5.49
200-Day moving average 3.98
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:12
Last split Date 22 Jul 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.76%
Return on equity -2.04%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.44
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.92
Total debt (mrq) -
Total Debt/Equity (mrq) 3.29
Current ratio (mrq) 5.86%
Book value per share (mrq) 2.66
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
